Background: Current assessments on topical treatment attributes in actinic keratosis (AK) do not evaluate safety, effectiveness, and satisfaction from both clinician and patient perspectives, creating an unmet need for more comprehensive AK-specific measures that fully capture the patient experience.
Objective: To develop an actinic keratosis-specific expert panel questionnaire (AK-EPQ) of patient-reported outcomes and clinician-reported outcomes for use in research studies.
Methods: Using interviews of patients with AK and targeted literature reviews, a 9-person consensus panel of dermatologists with expertise in AK treatment was convened to develop the AK-EPQ to assess AK-specific patient-reported outcomes and clinician-reported outcomes.
Background: Antibiotic resistance related to prolonged antibiotic use is an emerging threat to public health.
Objective: To evaluate recent trends in oral antibiotic use for acne treatment.
Methods: A retrospective study was conducted from January 2014 through September 2016 using the IBM MarketScan® claims database.